午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >BI-4142
BI-4142
  • BI-4142

BI-4142 NEW

Price $179 $463 $728
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-07-17

Product Details

Product Name: BI-4142 CAS No.: 2682003-36-5
Purity: 98.09% Supply Ability: 10g
Release date: 2025/07/17

Product Introduction

Bioactivity

NameBI-4142
DescriptionBI-4142 is an orally active, potent and selective HER2 inhibitor that inhibits cancer cell proliferation, suppresses her2-dependent cell lines and inhibits downstream signalling.
In vitroBI-4142 inhibits HER2-dependent cell lines and downstream signaling, with IC50 values of 10 nM, 18 nM, 270 nM, and 2400 nM against HEK HER2YVMA, Ba/F3 HER2YVMA, HEK EGFRWT, and Ba/F3 EGFRWT, respectively[1].BI-4142 (1 nM-5 μM, 72?h or 96?h) exhibits antiproliferative activity against tumor cells[1]. In the CaCo-2 assay, BI-4142 displays good permeability and no PgP-mediated efflux liability[1].
In vivoBI-4142 administered at doses ranging from 0 to 100 mg/kg, orally twice daily for 40 days, significantly inhibits tumor growth and suppresses oncogenic signaling[1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 80 mg/mL (153.38 mM), Sonication is recommended.
KeywordsHER2
Inhibitors Related(S)-Afatinib | Tucatinib | Terodiline | Tannic acid | Afatinib Dimaleate | CUDC-101 | Neratinib | Cisapride | Pyrotinib dimaleate | AG1557 | VU 0240551 | Rilzabrutinib
Related Compound LibrariesAnti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Anti-Ovarian Cancer Compound Library | Angiogenesis related Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | Immuno-Oncology Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$40.00/1kg
VIP6Y
Hebei Yanxi Chemical Co., Ltd.
2023-10-10
$0.00/100mg
VIP3Y
HangZhou RunYan Pharma Technology Co.,LTD.
2024-09-19
$0.00/1kg
VIP1Y
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2025-01-15
$0.00/100MG
VIP3Y
HangZhou RunYan Pharma Technology Co.,LTD.
2024-09-19
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY